Genomic-derived radiation dosage improves prediction of outcomes
- PMID: 34874554
- DOI: 10.3322/caac.21711
Genomic-derived radiation dosage improves prediction of outcomes
Comment on
-
Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis.Lancet Oncol. 2021 Sep;22(9):1221-1229. doi: 10.1016/S1470-2045(21)00347-8. Epub 2021 Aug 4. Lancet Oncol. 2021. PMID: 34363761
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
